{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:17:13Z","timestamp":1787318233534,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jchromb.2020.122433","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T07:10:00Z","timestamp":1604041800000},"page":"122433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Systematic development of a bioanalytical UPLC-MS\/MS method for estimation of risperidone and its active metabolite in long-acting microsphere formulation in rat plasma"],"prefix":"10.1016","volume":"1160","author":[{"given":"Rehan Abdur","family":"Rub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwar","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-5592","authenticated-orcid":false,"given":"Obaid","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed H.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan J.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2020.122433_b0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10928-006-9040-2","article-title":"Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder","volume":"34","author":"Vermeulen","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jchromb.2020.122433_b0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)13416-2","article-title":"Biochemical profile of risperidone, a new antipsychotic","volume":"247","author":"Leysen","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jchromb.2020.122433_b0015","first-page":"513","article-title":"The pharmacokinetics of risperidone in humans: a summary","volume":"55","author":"Heykants","year":"1994","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jchromb.2020.122433_b0020","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0090-9556(25)08211-X","article-title":"Absorption, metabolism, and excretion of risperidone in humans","volume":"21","author":"Mannens","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2020.122433_b0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1993.146","article-title":"Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects","volume":"54","author":"Huang","year":"1993","journal-title":"J Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2020.122433_b0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02245444","article-title":"Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat","volume":"114","author":"Van Beijsterveldt","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jchromb.2020.122433_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ddr.430330403","article-title":"In vivo pharmacological profile of 9-hydroxyrisperidone, the major metabolite of the novel antipsychotic risperidone","volume":"33","author":"Megen","year":"1994","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jchromb.2020.122433_b0040","unstructured":"R. Woestenborghs, I. Geuens, H. Lenoir, C. Janssen, J. Heykants, in: E. Reid, I.D. Wilson (Eds.), Methodological Surveys in Bio-chemistry and Analysis, Royal Society of Chemistry, vol. 20, 1990, 241."},{"key":"10.1016\/j.jchromb.2020.122433_b0045","first-page":"595","article-title":"Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia","volume":"19","author":"Nagasaki","year":"1999","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2020.122433_b0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0378-4347(93)80327-Z","article-title":"Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection","volume":"614","author":"Le Moing","year":"1993","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2020.122433_b0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1570-0232(02)00715-8","article-title":"Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry","volume":"783","author":"Remmerie","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2020.122433_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1365\/s10337-005-0506-y","article-title":"The validation of an LC-MS method for the determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma","volume":"61","author":"Zhang","year":"2005","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2020.122433_b0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.saa.2014.04.015","article-title":"Development and validation of a rapid stability indicating HPLC-method using monolithic stationary phase and two spectrophotometric methods for determination of antihistaminic acrivastine in capsules","volume":"130","author":"Gouda","year":"2014","journal-title":"Spectrochim. Acta Part A"},{"key":"10.1016\/j.jchromb.2020.122433_b0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/22297928.2018.1429305","article-title":"Development and Validation of QbD-driven bioanalytical LC-MS\/MS method for the quantification of paracetamol and diclofenac in human plasma","volume":"8","author":"Bhatt","year":"2018","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.jchromb.2020.122433_b0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10826076.2011.601493","article-title":"Development and validation of RP-HPLC method for quantitation of amoxicillin trihydrate in bulk and pharmaceutical formulation using Box-Behnken experimental design","volume":"35","author":"Beg","year":"2012","journal-title":"J. Liq. Chromatogr. Rel. Technol."},{"key":"10.1016\/j.jchromb.2020.122433_b0080","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/chromsci\/bmu165","article-title":"Development and validation of a stability-indicating liquid chromatographic method for estimating olmesartan medoxomil using Quality by Design","volume":"53","author":"Beg","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2020.122433_b0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/chromsci\/bmu228","article-title":"Ultrafast liquid chromatographic method development and its validation for quantification of telaprevir in pharmaceutical dosage form by using Quality by Design approach","volume":"53","author":"Panda","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2020.122433_b0090","doi-asserted-by":"crossref","unstructured":"S. Beg, S. Swain, M. Rahman, M.S. Hasnain, S.S. Imam, Chapter 3 - Application of Design of Experiments (DoE) in Pharmaceutical Product and Process Optimization. In: Pharmaceutical Quality by Design: Principles and Applications, 2019, pp. 43\u201364. https:\/\/doi.org\/10.1016\/B978-0-12-815799-2.00003-4.","DOI":"10.1016\/B978-0-12-815799-2.00003-4"},{"key":"10.1016\/j.jchromb.2020.122433_b0095","first-page":"70","article-title":"Developing \u201coptimized\u201d drug products employing \u201cdesigned\u201d experiments","volume":"6","author":"Singh","year":"2013","journal-title":"Chem. Ind. Dig."},{"key":"10.1016\/j.jchromb.2020.122433_b0100","doi-asserted-by":"crossref","unstructured":"S. Beg, M.S. Hasnain, M. Rahman, S. Swain, Chapter 1 - Introduction to Quality by Design (QbD): Fundamentals, Principles, and Applications, in: Pharmaceutical Quality by Design: Principles and Applications, 2019, pp. 1\u201317. https:\/\/doi.org\/10.1016\/B978-0-12-815799-2.00001-0.","DOI":"10.1016\/B978-0-12-815799-2.00001-0"},{"key":"10.1016\/j.jchromb.2020.122433_b0105","unstructured":"US Food and Drug Administration Guidance for Industry, Bioanalytical method validation, 2013. Available at: http:\/\/www.fda.gov\/cvm."},{"key":"10.1016\/j.jchromb.2020.122433_b0110","unstructured":"International Conference on Harmonization. Validation of analytical procedures: methodology ICH Q2 (R1), 2005. Available at: http:\/\/www.ich.org\/fileadmin\/PublicWebSite\/ICHProducts\/Guidelines\/Quality\/Q2R1\/Step4\/Q2R1Guideline.pdf."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322031309X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002322031309X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:02:13Z","timestamp":1761606133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002322031309X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"alternative-id":["S157002322031309X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122433","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic development of a bioanalytical UPLC-MS\/MS method for estimation of risperidone and its active metabolite in long-acting microsphere formulation in rat plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2020.122433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122433"}}